Rhythm Pharmaceuticals (RYTM) EPS (Basic) (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported EPS (Basic) of -$0.83 for Q1 2026, down 2.47% year-over-year from -$0.85 in Q1 2025, and down 13.7% quarter-over-quarter from -$0.73 in Q4 2025.
Rhythm Pharmaceuticals (RYTM) EPS (Basic) (2016 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 11 years of EPS (Basic) data on file, last reported at -$0.83 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$0.83, down 2.47% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.13 (down 11.39% YoY), and the FY2025 annual result was -$3.11, up 28.34% from the prior year.
- EPS (Basic) declined to -$0.83 in Q1 2026 per RYTM's latest filing, from -$0.73 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.55 in Q2 2024 and troughed at -$2.35 in Q1 2024.
- A 5-year average of -$0.88 and a median of -$0.79 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) sank 214.13% in 2022, then surged 65.53% in 2025.
- A 5-year view of EPS (Basic) shows it stood at -$0.74 in 2022, then rose by 5.41% to -$0.7 in 2023, then declined by 2.86% to -$0.72 in 2024, then declined by 1.39% to -$0.73 in 2025, then dropped by 13.7% to -$0.83 in 2026.
- Business Quant data shows RYTM's EPS (Basic) at -$0.83 in Q1 2026, -$0.73 in Q4 2025, and -$0.82 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Rhythm Pharmaceuticals | 6.59 Bn | 6.25 Bn | 52.96 Mn | -0.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.83 |
| Dec 31, 2025 | -0.73 |
| Sep 30, 2025 | -0.82 |
| Jun 30, 2025 | -0.75 |
| Mar 31, 2025 | -0.81 |
| Dec 31, 2024 | -0.72 |
| Sep 30, 2024 | -0.73 |
| Jun 30, 2024 | -0.55 |
| Mar 31, 2024 | -2.35 |
| Dec 31, 2023 | -0.70 |
| Sep 30, 2023 | -0.76 |
| Jun 30, 2023 | -0.82 |
| Mar 31, 2023 | -0.92 |
| Dec 31, 2022 | -0.74 |
| Sep 30, 2022 | -0.79 |
| Jun 30, 2022 | -0.89 |
| Mar 31, 2022 | -1.05 |
| Dec 31, 2021 | -0.86 |
| Sep 30, 2021 | -0.70 |
| Jun 30, 2021 | -0.70 |